NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 22, 2025.

image for news ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN

IJR Unlocks The Hidden Small-Cap Premium — Negative

IJR   Seeking Alpha — May 29, 2025

IJR could offer a compelling mean reversion trade, capitalizing on the unusually wide small-cap premium and valuation gap versus large caps. This is because IJR tracks the S&P SmallCap 600, which better selects profitable small caps. And because the forward P/E of profitable small-cap companies is lower than that of unprofitable ones, signaling in my opinion, a technical inconsistency in favor of the S&P 600.

image for news IJR Unlocks The Hidden Small-Cap Premium

Ambarella, Inc. (AMBA) Q1 2026 Earnings Call Transcript — Neutral

AMBA   Seeking Alpha — May 29, 2025

Ambarella, Inc. (NASDAQ:AMBA ) Q1 2026 Results Conference Call May 29, 2025 4:30 PM ET Company Participants Louis Gerhardy - Vice President, Corporate Development Dr. Fermi Wang - President and Chief Executive Officer John Young - Chief Financial Officer Conference Call Participants Christopher Rolland - Susquehanna Tore Svanberg - Stifel Kevin Cassidy - Rosenblatt Securities Joe Moore - Morgan Stanley Suji Desilva - ROTH Capital Shadi Mitwalli - Needham & Company Gus Richard - Northland Capital Markets Martin Yang - Oppenheimer Operator Hello, everyone, and welcome to Ambarella's First Quarter Fiscal Year 2026 Earnings Call. At this time, all participants …

image for news Ambarella, Inc. (AMBA) Q1 2026 Earnings Call Transcript

Compared to Estimates, Dell Technologies (DELL) Q1 Earnings: A Look at Key Metrics — Positive

DELL   Zacks Investment Research — May 29, 2025

Although the revenue and EPS for Dell Technologies (DELL) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Compared to Estimates, Dell Technologies (DELL) Q1 Earnings: A Look at Key Metrics

Compared to Estimates, Red Robin (RRGB) Q1 Earnings: A Look at Key Metrics — Positive

RRGB   Zacks Investment Research — May 29, 2025

The headline numbers for Red Robin (RRGB) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

image for news Compared to Estimates, Red Robin (RRGB) Q1 Earnings: A Look at Key Metrics

Here's What Key Metrics Tell Us About Elastic (ESTC) Q4 Earnings — Positive

ESTC   Zacks Investment Research — May 29, 2025

The headline numbers for Elastic (ESTC) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

image for news Here's What Key Metrics Tell Us About Elastic (ESTC) Q4 Earnings

Costco (COST) Reports Q3 Earnings: What Key Metrics Have to Say — Positive

COST   Zacks Investment Research — May 29, 2025

The headline numbers for Costco (COST) give insight into how the company performed in the quarter ended May 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

image for news Costco (COST) Reports Q3 Earnings: What Key Metrics Have to Say

Here's What Key Metrics Tell Us About Marvell (MRVL) Q1 Earnings — Positive

MRVL   Zacks Investment Research — May 29, 2025

Although the revenue and EPS for Marvell (MRVL) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Here's What Key Metrics Tell Us About Marvell (MRVL) Q1 Earnings

Zscaler (ZS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive

ZS   Zacks Investment Research — May 29, 2025

Although the revenue and EPS for Zscaler (ZS) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Zscaler (ZS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Compared to Estimates, Ulta (ULTA) Q1 Earnings: A Look at Key Metrics — Positive

ULTA   Zacks Investment Research — May 29, 2025

Although the revenue and EPS for Ulta (ULTA) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Compared to Estimates, Ulta (ULTA) Q1 Earnings: A Look at Key Metrics

UiPath (PATH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive

PATH   Zacks Investment Research — May 29, 2025

Although the revenue and EPS for UiPath (PATH) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news UiPath (PATH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

KLA (KLAC) Stock Declines While Market Improves: Some Information for Investors — Neutral

KLAC   Zacks Investment Research — May 29, 2025

KLA (KLAC) concluded the recent trading session at $773.97, signifying a -0.45% move from its prior day's close.

image for news KLA (KLAC) Stock Declines While Market Improves: Some Information for Investors

In the latest trading session, Boston Scientific (BSX) closed at $104.50, marking a -0.01% move from the previous day.

image for news Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors

Tenet Healthcare (THC) Rises Higher Than Market: Key Facts — Neutral

THC   Zacks Investment Research — May 29, 2025

In the latest trading session, Tenet Healthcare (THC) closed at $166.26, marking a +0.97% move from the previous day.

image for news Tenet Healthcare (THC) Rises Higher Than Market: Key Facts

Teradyne (TER) Rises Higher Than Market: Key Facts — Neutral

TER   Zacks Investment Research — May 29, 2025

In the latest trading session, Teradyne (TER) closed at $80.98, marking a +0.91% move from the previous day.

image for news Teradyne (TER) Rises Higher Than Market: Key Facts

United Airlines (UAL) Rises Higher Than Market: Key Facts — Neutral

UAL   Zacks Investment Research — May 29, 2025

In the closing of the recent trading day, United Airlines (UAL) stood at $78.57, denoting a +1.38% change from the preceding trading day.

image for news United Airlines (UAL) Rises Higher Than Market: Key Facts

In the latest trading session, Levi Strauss (LEVI) closed at $17.74, marking a -1.66% move from the previous day.

image for news Levi Strauss (LEVI) Stock Declines While Market Improves: Some Information for Investors

The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say — Positive

COO   Zacks Investment Research — May 29, 2025

Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say

Zillow Group, Inc. (NASDAQ:Z ) Bernstein 41st Annual Strategic Decisions Conference May 29, 2025 1:30 PM ET Company Participants Jeremy Wacksman - CEO Conference Call Participants Nikhil Devnani - Bernstein Nikhil Devnani Here we go. Good afternoon, everybody.

image for news Zillow Group, Inc. (Z) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

Banco Macro S.A. (BMA) Q1 2025 Earnings Call Transcript — Neutral

BMA   Seeking Alpha — May 29, 2025

Banco Macro S.A. (NYSE:BMA ) Q1 2025 Earnings Conference Call May 29, 2025 11:00 AM ET Company Participants Nicolas Torres - IR Jorge Scarinci - CFO Conference Call Participants Brian Flores - Citi Ernesto Gabilondo - Bank of America Carlos Gomez-Lopez - HSBC Operator Good morning, ladies and gentlemen, and thank you for waiting.

image for news Banco Macro S.A. (BMA) Q1 2025 Earnings Call Transcript